Charles Bancroft

Non Executive / Member
Login/ Register  to follow report
Company:

About

Charlie was appointed as an Independent Non-Executive Director on 1 May 2020 and as the Senior Independent Non-Executive Director on 18 July 2022.

Charlie has a wealth of financial and management experience in global biopharma.

Charlie retired from a successful career at Bristol Myers Squibb (BMS) in March 2020 where he held a number of leadership roles in commercial, strategy and finance. Beginning his career at BMS in 1984, he held positions of increasing responsibility within the finance organisation and had commercial operational responsibility for Latin America, Middle East, Africa, Canada, Japan and several Pacific Rim countries.

He was appointed Chief Financial Officer in 2010, Chief Financial Officer and Executive Vice President, Global Business Operations in 2016 and Executive Vice President and Head of Integration and Strategy & Business Development in 2019. Charlie successfully steered BMS through a period of strategic transformation, including its $74bn acquisition of Celgene.

Charlie also served as a member of the Board of Colgate-Palmolive Company from 2017 until March 2020.

 

Personal Details

Title: Mr
Surname: Bancroft
DoB: 01/01/1961
Age: 65 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: Undergraduate Degree
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

 

Working history

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
GlaxoSmithKline plcBoardMember01/05/2020

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF